Skip to main content
. 2021 Jan 15;11:547436. doi: 10.3389/fphar.2020.547436

FIGURE 6.

FIGURE 6

Origin of the proangiogenesis property of EFEMP1. (A) Tube formation of wild type (WT) HUVECs treated with different concentrations (0 µg/ml, 1 µg/ml, 2 µg/ml, 4 µg/ml, and 8 µg/ml) of recombinant human fibulin-3 protein and shEFEMP1 HUVECs treated with or without fibulin-3 protein was tested. (B) Proliferation of wild type (WT) HUVECs treated with different concentrations (0 µg/ml, 1 µg/ml, 2 µg/ml, 4 µg/ml, and 8 µg/ml) of recombinant human fibulin-3 protein, WT HUVECs in fibulin-3 coated or uncoated plates, and shEFEMP1 HUVECs treated with or without fibulin-3 protein was tested using EdU assay. # p > 0.05.